Dr Inder Paul Singh, MD, president of The Eye Centers of Racine and Kenosha, Wisconsin and consultant and speaker for Ocular Therapeutix, has conducted

LBS-008, an oral therapy for Stargardt disease (STGD1), by Belite Bio, Inc, a clinical stage biopharmaceutical drug development company, has been granted Fast Track

A new study by the University of South Australia (UniSA) has found that millions of older people with poor vision are at risk of

The National Medicines Policy Review must be prioritised by an incoming Australian Government, according to Medicines Australia.